secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rallybio Corp (RLYB)
CIK:        0001739410
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001739410-24-000105
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rallybio Executive Chairman Martin Mackay to resign employment, stay as Chairman and consultant
--------------------------------------------------------------------------------

- Martin Mackay will resign as Executive Chairman and employee effective Dec 31, 2024; no severance paid.
- He will remain as Chairman of the Board; consulting agreement from Jan 1, 2025 to Jan 1, 2026 at $18,750/month.
- Outstanding unvested time-based equity awards will vest immediately upon a Change of Control during consultancy.
- Dr. Mackay eligible for 2024 annual bonus based on performance, paid at same time as employees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739410/000173941024000105/0001739410-24-000105-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739410/000173941024000105/rlyb-20240723.htm
  HTML page:      https://secwatch.observer/filing/0001739410-24-000105

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer